$150,000 of CINTAS lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"PL 115-97, The Tax Cuts and Jobs Act and General Tax Provisions Reauthorization of Trade Preference Programs including Haiti HOPE/HELP Acts and the African Growth and Opportunity Act (S. 742 and H.R. 1625); tariffs Reauthorization of Trade Preference Programs including Haiti HOPE/HELP Acts and the African Growth and Opportunity Act (S. 742 and H.R. 1625); tariffs Increasing defibrillation access including HR 2370/S. 1024, Access to AEDs Act and HR 6829, the HEARTS Act (Public Law 118-176) General workplace safety and the Voluntary Protection Program Act (S. 1417 and H.R. 2844)"
You can find more data on corporate lobbying on Quiver Quantitative.
CTAS Congressional Stock Trading
Members of Congress have traded $CTAS stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CTAS stock by members of Congress over the last 6 months:
- REPRESENTATIVE RICK LARSEN purchased up to $15,000 on 01/07.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CTAS Insider Trading Activity
CTAS insiders have traded $CTAS stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CTAS stock by insiders over the last 6 months:
- RONALD W TYSOE sold 8,521 shares for an estimated $1,780,548
- JIM ROZAKIS (Executive Vice President & COO) sold 2,000 shares for an estimated $380,740
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CTAS Hedge Fund Activity
We have seen 622 institutional investors add shares of CTAS stock to their portfolio, and 541 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC removed 4,139,617 shares (-10.0%) from their portfolio in Q4 2024, for an estimated $756,308,025
- WINSLOW CAPITAL MANAGEMENT, LLC added 1,073,110 shares (+inf%) to their portfolio in Q4 2024, for an estimated $196,057,197
- BLACKROCK, INC. added 975,736 shares (+3.5%) to their portfolio in Q4 2024, for an estimated $178,266,967
- UBS GROUP AG added 621,283 shares (+46.6%) to their portfolio in Q4 2024, for an estimated $113,508,404
- LEGAL & GENERAL GROUP PLC removed 598,600 shares (-19.7%) from their portfolio in Q4 2024, for an estimated $109,364,220
- HRT FINANCIAL LP added 589,526 shares (+666.5%) to their portfolio in Q4 2024, for an estimated $107,706,400
- ACADIAN ASSET MANAGEMENT LLC added 587,538 shares (+30.6%) to their portfolio in Q4 2024, for an estimated $107,343,192
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CTAS Analyst Ratings
Wall Street analysts have issued reports on $CTAS in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Underweight" rating on 12/20/2024
To track analyst ratings and price targets for CTAS, check out Quiver Quantitative's $CTAS forecast page.
CTAS Price Targets
Multiple analysts have issued price targets for $CTAS recently. We have seen 3 analysts offer price targets for $CTAS in the last 6 months, with a median target of $202.0.
Here are some recent targets:
- An analyst from Robert W. Baird set a target price of $227.0 on 03/27/2025
- Jason Haas from Wells Fargo set a target price of $184.0 on 12/20/2024
- Toni Kaplan from Morgan Stanley set a target price of $202.0 on 12/12/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
